In Promising Trial, Pancreatic Cancer Vaccine Helped Patients Live Longer
As NBC News reported, people with pancreatic cancer survived for an average of 29 months and lived recurrence-free for more than 15 months post-vaccination — far longer than the rates of resectable cancers. A randomized phase 2 trial is being held to test the durability of the vaccine.